We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Stratasys
SSYS
$774M
| $104M | 0.11% |
4,006,200
+721,200
| +22% | +$14.7M |
|
127
Sanofi
SNY
$104B
| $102M | 0.11% |
2,549,382
-218,200
| -8% | -$8.77M |
|
|
S
128
DELISTED
Sprint Corporation
S
| $101M | 0.1% |
28,890,500
+1,240,500
| +4% | +$3.96M |
|
129
Descartes Systems
DSGX
$6.82B
| $97M | 0.1% |
4,971,090
| – | – |
|
|
VMW
130
DELISTED
VMware, Inc
VMW
| $93.1M | 0.1% |
1,780,187
+278,643
| +19% | +$13.8M |
|
131
Gildan
GIL
$10.6B
| $92.9M | 0.1% |
3,043,300
-538,400
| -15% | -$14.3M |
|
132
Charles River Laboratories
CRL
$12.8B
| $92.1M | 0.1% |
1,213,160
-58,222
| -5% | -$4.31M |
|
133
Waters Corp
WAT
$39.9B
| $85.9M | 0.09% |
650,867
-250
| -0% | -$31.2K |
|
134
VF Corp
VFC
$5.89B
| $82.4M | 0.09% |
1,351,501
+33,984
| +3% | +$1.97M |
|
135
Celanese
CE
$4.82B
| $80.6M | 0.08% |
1,230,800
| – | – |
|
|
CPHD
136
DELISTED
Cepheid Inc
CPHD
| $80.3M | 0.08% |
2,407,500
+100
| +0% | +$3.14K |
|
137
Jabil
JBL
$35.8B
| $79.5M | 0.08% |
4,125,875
+35,925
| +0.9% | +$725K |
|
|
NBL
138
DELISTED
Noble Energy, Inc.
NBL
| $79.3M | 0.08% |
2,523,800
-125,000
| -5% | -$3.82M |
|
139
DuPont de Nemours
DD
$19.2B
| $79.1M | 0.08% |
614,011
+11,758
| +2% | +$1.41M |
|
|
EPZM
140
DELISTED
Epizyme, Inc
EPZM
| $79M | 0.08% |
6,518,627
+1,273,000
| +24% | +$12.9M |
|
141
Magnite
MGNI
$3.55B
| $79M | 0.08% |
4,321,300
+1,924,400
| +80% | +$29.5M |
|
142
F5
FFIV
$22.7B
| $76.1M | 0.08% |
718,550
-38,950
| -5% | -$3.73M |
|
143
Entegris
ENTG
$23.2B
| $71.4M | 0.07% |
5,240,850
+14,200
| +0.3% | +$172K |
|
|
TWC
144
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $71.2M | 0.07% |
348,004
| – | – |
|
145
ExxonMobil
XOM
$634B
| $66M | 0.07% |
789,212
| – | – |
|
146
Universal Display
OLED
$4.19B
| $65.3M | 0.07% |
1,207,875
+16,800
| +1% | +$821K |
|
|
CRAY
147
DELISTED
Cray, Inc.
CRAY
| $64.3M | 0.07% |
1,534,750
-564,775
| -27% | -$21.5M |
|
148
Xencor
XNCR
$1.55B
| $63.5M | 0.07% |
4,731,995
+1,115,081
| +31% | +$13.2M |
|
|
CTRA
149
DELISTED
Coterra Energy
CTRA
| $61.8M | 0.06% |
2,723,400
-10,000
| -0.4% | -$201K |
|
150
FormFactor
FORM
$9.17B
| $60.6M | 0.06% |
8,336,959
+114,041
| +1% | +$866K |
|
Similar funds
VAM
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.